Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human study of BAY 3713372 in MTAP-deleted solid tumors
CTR20254258Phase 2Active
- Sponsor
- Bayer
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BAY 3713372 in Nonhematologic neoplasms, sponsored by Bayer. Started Jan 2026; status: active.
02
Drugs
BAY 3713372
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20254258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254258.